New Research on Treatment for Ovarian Cancer: More Women Are Now Eligible to Receive a PARP Inhibitor

New research shows that ovarian cancers without BRCA mutations—as well as cancers that haven't responded to chemotherapy in the past—may benefit from PARP inhibitors, too.

Published Jul 5, 2019


Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.